van Kol, K.; Ebisch, R.; Piek, J.; Beugeling, M.; Vergeldt, T.; Bekkers, R.
Adjuvant Hysterectomy for Cervical Cancer Patients Treated with Chemoradiation Therapy: A Systematic Review on the Pathology-Proven Residual Disease Rate. Cancers 2021, 13, 6190.
https://doi.org/10.3390/cancers13246190
AMA Style
van Kol K, Ebisch R, Piek J, Beugeling M, Vergeldt T, Bekkers R.
Adjuvant Hysterectomy for Cervical Cancer Patients Treated with Chemoradiation Therapy: A Systematic Review on the Pathology-Proven Residual Disease Rate. Cancers. 2021; 13(24):6190.
https://doi.org/10.3390/cancers13246190
Chicago/Turabian Style
van Kol, Kim, Renée Ebisch, Jurgen Piek, Maaike Beugeling, Tineke Vergeldt, and Ruud Bekkers.
2021. "Adjuvant Hysterectomy for Cervical Cancer Patients Treated with Chemoradiation Therapy: A Systematic Review on the Pathology-Proven Residual Disease Rate" Cancers 13, no. 24: 6190.
https://doi.org/10.3390/cancers13246190
APA Style
van Kol, K., Ebisch, R., Piek, J., Beugeling, M., Vergeldt, T., & Bekkers, R.
(2021). Adjuvant Hysterectomy for Cervical Cancer Patients Treated with Chemoradiation Therapy: A Systematic Review on the Pathology-Proven Residual Disease Rate. Cancers, 13(24), 6190.
https://doi.org/10.3390/cancers13246190